Cargando…
Synthetic approaches to potent heterocyclic inhibitors of tuberculosis: A decade review
Tuberculosis (TB) continues to be a significant global health concern with about 1.5 million deaths annually. Despite efforts to develop more efficient vaccines, reliable diagnostics, and chemotherapeutics, tuberculosis has become a concern to world health due to HIV, the rapid growth of bacteria th...
Autores principales: | Dasmahapatra, Upala, Chanda, Kaushik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661889/ https://www.ncbi.nlm.nih.gov/pubmed/36386156 http://dx.doi.org/10.3389/fphar.2022.1021216 |
Ejemplares similares
-
Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances
por: Vittorio, Serena, et al.
Publicado: (2023) -
CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist
por: Kevin, Richard C., et al.
Publicado: (2019) -
In-silico molecular modelling, MM/GBSA binding free energy and molecular dynamics simulation study of novel pyrido fused imidazo[4,5-c]quinolines as potential anti-tumor agents
por: Dasmahapatra, Upala, et al.
Publicado: (2022) -
Identification of a potent dual-function inhibitor for hIMPDH isoforms by computer-aided drug discovery approaches
por: Yazdani, Meysam, et al.
Publicado: (2022) -
Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma †
por: Musumeci, Francesca, et al.
Publicado: (2021)